期刊文献+

Measurement of Intraocular Concentrations of Etoposide after Systemic and Local Administration

Measurement of Intraocular Concentrations of Etoposide after Systemic and Local Administration
下载PDF
导出
摘要 Purpose: To determine and compare the concentrations of etoposide achieved in the aqueous and vitreous humors after intravenous and subconjunctival administration . Methods: Eight New Zealand rabbits were treated with etoposide (5mg/kg) intravenous and etoposide (2.5mg/ml,0.5ml) subconjunctival respectively. The samples of the aqueous and vitreous humors of rabbits were drawed at 1,2,3 hours after the end of infusion. The concentrations of the etoposide were determined by high-performance liquid chromatography. A Diamonsil TM C18 column ( 6×40 mm, 3 μm ) with a mobile phase of 400 ml of methanol and 600 ml of 100 mmol.L-1 sodium dihydrogen phosphate with 0.02 mmol.L-1 dioctyl sodium sulfosuccinate and 0.5% triethylanine (pH value was adjusted to 6 by phosphoric acid) was used. The detective wavelength was at 235nm and the flow rate was 1.0ml.min-1.Results: The concentrations of etoposide in aqueous and vitreous humors after administr-ated in intravenous for 1, 2, 3 hours were 38.5, 52.2, 44.1(ng/ml) and 12.0, 25.1, 18.0(ng/ml) respectively. The concentrations of etoposide in aqueous and vitreous humors after infused in subconjunctival for 1,2,3 hours were 98.0, 113.0, 99.0 (ng/ml) and 43.7, 66.7, 32.4 (ng/ml) respectively. The concentrations in the aqueous and vitreous humor after local administrated were 2 to 4 times higher than those obtained after intravenous administration. There are statistical significance between the concentrations of etoposide of aqueous and vitreous humor after intravenous and subconjunctival administration .Conclusions: The delivery of subconjunctival of etoposide results in higher concentrations in aqueous and vitreous humors than intravenous administration. These results suggest that local administration of chemotherapeutic agents should be more effective for retinoblas-toma chemotherapy than systemic administration. Purpose: To determine and compare the concentrations of etoposide achieved in the aqueous and vitreous humors after intravenous and subconjunctival administration . Methods: Eight New Zealand rabbits were treated with etoposide (5mg/kg) intravenous and etoposide (2.5mg/ml,0.5ml) subconjunctival respectively. The samples of the aqueous and vitreous humors of rabbits were drawed at 1,2,3 hours after the end of infusion. The concentrations of the etoposide were determined by high-performance liquid chromatography. A Diamonsil TM C18 column ( 6×40 mm, 3 μm ) with a mobile phase of 400 ml of methanol and 600 ml of 100 mmol.L-1 sodium dihydrogen phosphate with 0.02 mmol.L-1 dioctyl sodium sulfosuccinate and 0.5% triethylanine (pH value was adjusted to 6 by phosphoric acid) was used. The detective wavelength was at 235nm and the flow rate was 1.0ml.min-1.Results: The concentrations of etoposide in aqueous and vitreous humors after administr-ated in intravenous for 1, 2, 3 hours were 38.5, 52.2, 44.1(ng/ml) and 12.0, 25.1, 18.0(ng/ml) respectively. The concentrations of etoposide in aqueous and vitreous humors after infused in subconjunctival for 1,2,3 hours were 98.0, 113.0, 99.0 (ng/ml) and 43.7, 66.7, 32.4 (ng/ml) respectively. The concentrations in the aqueous and vitreous humor after local administrated were 2 to 4 times higher than those obtained after intravenous administration. There are statistical significance between the concentrations of etoposide of aqueous and vitreous humor after intravenous and subconjunctival administration .Conclusions: The delivery of subconjunctival of etoposide results in higher concentrations in aqueous and vitreous humors than intravenous administration. These results suggest that local administration of chemotherapeutic agents should be more effective for retinoblas-toma chemotherapy than systemic administration.
出处 《Eye Science》 CAS 2004年第3期178-180,186,共4页 眼科学报(英文版)
基金 ThisstudywassupportedbytheMedicalScienceTechnologyandResearchFundofGuangdongProvince(grantno.A2004217) aReyprojectgrandoftheScienceandTechnologyofGuangdongProvince(grantNo.B30104)
关键词 测量 眼内浓度 足叶乙甙 全身性 局限性 服药方法 结膜下给药 subconjunctival administration Etoposide intraocular concentration
  • 相关文献

参考文献10

  • 1Gallic BL, Budning A, Deboer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol, 1996; 114: 1321-1328.
  • 2Luo YX, Yang LH. The measurement study of chemotherapeutic agent teniposide. Pharmacol Analysis Res, 1994; 14(5) :25-27.
  • 3Motzer R J, Gulati SC, Tong WP, et al. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplatation in patients with refractory germ cell tumor. Cancer Res, 1993;53 : 3730-3735.
  • 4Mendelsohn ME, Abramson DH, Madden T, et al. Intraocular Concentrations of Chem-otherapeutic Agents After Systemic or Local Admin-istration.Arch Ophthalmol, 1998; 116:1209-1212.
  • 5Zelter M, Damel A, Gonzalez G, et al. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer, 1991 ; 68(8) : 1685-1690.
  • 6Stevenson KE, Hungerford J, Garner A. Local extraocular extension of retinoblastoma following intraocular surgery. Br J Ophthalmol, 1989 ;73 :739-742.
  • 7Murray TG, Stern WH, Chin DH. MacGowan Smith EA. Collagen shield heparin delivery for prevention of postoperative fibrin. Arch Ophthalmol, 1990;108 : 104-106.
  • 8Murray TG, Jaffe GJ, McKay BS, Han DP, Burke JM,Abrams GW. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery. Refract Corneal Surg, 1992; 8:44-53.
  • 9Li Fengming. Ophthamology. Beijing. Publishing company of People Healthy. 1996; 625.
  • 10Rubsamen PE, Cousin SW. Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy. Retina, 1997; 17:44-48.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部